Out of the Crisis #12: Curative founder Fred Turner and Celine Halioua on diagnostic supply chains, scaling up testing, and partnering with government
Startup Lessons Learned
JULY 2, 2020
At the beginning of this year, Fred Turner was building a biotech company in the Bay Area to work on sepsis detection. When he realized that the technology the company had built could potentially be used to test for COVID-19, he jumped in feet first. In one weekend, his assumption was proved correct. A full transcript is below.
Let's personalize your content